Top Markets
#1 Official Trump Official Trump +33.51%
#2 Siacoin Siacoin +20.98%
#3 Melania Meme Melania Meme +19.05%
#4 EXOD EXOD +18.93%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +18.64%
#6 MowCat MowCat +18.17%
#7 POL (ex-MATIC) POL (ex-MATIC) +17.47%
#8 Wrapped POL Wrapped POL +16.96%
#9 Islamic Coin Islamic Coin +16.11%
#10 Siren Siren +15.86%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
Abliva AB (publ) Abliva AB (publ)

Abliva AB (publ)

ABLI
Rank in Stocks #22998
Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000,... Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000, focuses on developing innovative therapeutic solutions for primary mitochondrial diseases. Its pipeline includes KL1333, currently in Phase 2/3 clinical trials for the long-term management of these conditions, and NV354, which is preparing for clinical studies targeting primary mitochondrial diseases specifically linked to Complex I deficiency. The company is also advancing NeuroSTAT through a Phase 1b/2a clinical study for the treatment of traumatic brain injury. Abliva maintains strategic partnerships with entities such as Isomerase, Yungjin Pharm, the University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The firm rebranded as Abliva AB (publ) in May 2020, having previously been known as NeuroVive Pharmaceutical AB (publ).
Share Price
$0.04959193
Last synced: 2025-03-17
Market Cap
$79.94M
Change (1 day)
13.49%
Change (1 year)
0.00%
Country
SE
Trade Abliva AB (publ) (ABLI)

Category

Healthcare
Number of shares outstanding for Abliva AB (publ) (ABLI)
Number of shares outstanding as of August 2026: 0
According to Abliva AB (publ) latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Abliva AB (publ) (ABLI) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH